Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
The top July 4 fireworks, festivals, and food trucks in the Triangle + Maps
Recommended
Do these things indoors and out to keep your home cool in summer heat
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
224.61
-4.21 (-1.84%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
...
32
33
34
35
36
37
38
39
Next >
Unusual Options Activity Insight: Biogen
July 06, 2021
Biogen (NASDAQ:BIIB) shares experienced unusual options activity on Tuesday. The stock price moved down to $343.7 following the option alert. Sentiment: NEUTRAL Option Type:...
Via
Benzinga
Friday Trades And June Summary
July 03, 2021
Trading performance has been very good year to date. I had thought I needed to tighten my belt but I made it by just fine.
Via
Talk Markets
Lundbeck Out Licenses Flopped Alzheimer's Drug In Wake Of Biogen's Controversial Success With Aducanumab
July 02, 2021
Privately-held Denovo Biopharma LLC has in-licensed global rights for idalopirdine from H. Lundbeck A/S (OTC: HLUYY) for all indications. The deal...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
July 01, 2021
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive...
Via
Benzinga
Analyzing Biogen's Unusual Options Activity
June 30, 2021
On Wednesday, shares of Biogen (NASDAQ:BIIB) saw unusual options activity. After the option alert, the stock price moved up to $348.49. Sentiment: BEARISH Option Type: TRADE...
Via
Benzinga
What 17 Analyst Ratings Have To Say About Biogen
June 28, 2021
Analysts have provided the following ratings for Biogen (NASDAQ:
Via
Benzinga
How Biogen Made an Enemy of 1 of the Biggest Supporters of Its Alzheimer's Disease Drug
June 30, 2021
A nonprofit group doesn't like a recent move by Biogen.
Via
The Motley Fool
Exposures
Product Safety
3 Better Alzheimer’s Drug Stocks to Buy Instead of Biogen
June 29, 2021
These drug stocks are in competition with Biogen for an Alzheimer's treatment, and can break out in a similar fashion offering better value.
Via
InvestorPlace
Could Biogen's Big Win With Aduhelm Become a Big Liability?
June 29, 2021
It's looking more and more likely.
Via
The Motley Fool
How Bad Is Biogen's Latest Bad News?
June 29, 2021
The drugmaker has had one big clinical setback and another less serious disappointment in recent weeks.
Via
The Motley Fool
Facebook And Nvidia Lead The QQQ Higher Monday
June 28, 2021
The Nasdaq was trading sharply higher throughout Monday’s session amid a rebound in growth and tech names. The Inve...
Via
Benzinga
Earnings Roundup: Adobe, Kroger, The Honest Company, and More
June 28, 2021
Discussing the latest news and how to move from growth-focused investing to a value approach.
Via
The Motley Fool
Biogen's Costly Alzheimer's Treatment May Face Restricted Medicare Access: WSJ
June 28, 2021
The recent approval of Biogen Inc's (NASDAQ: BIIB) high-price Alzheimer's drug is raising questions about who will have access to the $56,000/year...
Via
Benzinga
Longeveron, Armed with Positive Results of Phase I Clinical Study of Lomecel-B Cell Therapy for Alzheimer's Disease, Presenting at AAIC & Headed to Phase 2 Trials
June 28, 2021
Longeveron CEO Geoff Green presented at the Benzinga Global Small Cap Conference held on May 13-14, 2021. In addition to sharing the company’s corporate outlook, Green...
Via
Benzinga
New Alzheimer’s Treatment Is A Huge Catalyst for Biogen
June 28, 2021
BIIB stock was boosted when its Alzheimer's drug was approved. The company's strong financials can sustain the stock's growth.
Via
InvestorPlace
10 Biggest Price Target Changes For Monday
June 28, 2021
Barclays raised the price target for Accenture plc (NYSE:
Via
Benzinga
The Upside for Biogen Is Absolutely Wild
June 26, 2021
It's hard to believe how large Biogen's market opportunity is, now that the FDA has approved its Alzheimer's drug.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Product Safety
Why Biogen's FDA Approval Is Shocking
June 26, 2021
Many doctors don't like the drug, and the trial data was underwhelming. Nonetheless, Biogen's Alzheimer's drug was approved-- and the market opportunity is huge.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Product Safety
Is It Too Late to Buy Cassava Sciences Stock?
June 26, 2021
Just because the stock has had a massive run doesn't mean its biggest gains are behind it.
Via
The Motley Fool
Alzheimer's Biotech Acumen Pharmaceuticals Prices $125M IPO Soon After Biogen's Aduhelm Approval
June 25, 2021
Acumen Pharmaceuticals Inc has set the terms for its IPO to raise around $125 million to take ACU193, an antibody against amyloid-beta oligomers, to the end of phase 2 in...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Stock Market Rally Revs To New Highs; Nike, Google, FedEx, Eli Lilly, Amazon In Focus: Weekly Review
June 25, 2021
The Nasdaq and S&P 500 hit highs as the stock market rally perked up, helped by a Biden infrastructure deal. Nike soared on earnings.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Crazy Thursday
June 24, 2021
Today the US stock market went ballistic probably because of a higher joblessness level than expected.
Via
Talk Markets
3 Biotech Stocks Ready for Big Breakthroughs Like Biogen
June 24, 2021
This could be a breakthrough year for these three biotech stocks, resulting in massive gains for their stockholders similar to Biogen.
Via
InvestorPlace
Lilly Stock Hits Record High On Key Alzheimer's Win, Looking To Follow Biogen
June 24, 2021
Eli Lilly's experimental Alzheimer's treatment snagged a key FDA designation on Thursday. LLY stock surged to a record high.
Via
Investor's Business Daily
Exposures
Product Safety
Why Eli Lilly Stock Is Soaring Today
June 24, 2021
The company's promising Alzheimer's disease drug won FDA Breakthrough Therapy designation.
Via
The Motley Fool
Exposures
Product Safety
Eli Lilly Jumps On Expedited Plans For Alzheimer's Drug, Biogen Falls
June 24, 2021
Eli Lilly announced that the Food and Drug Administration granted Breakthrough Therapy designation for donanemab, its investigational antibody therapy for Alzheimer's disease.
Via
Talk Markets
PreMarket Prep Recap: The 4 Stocks Dennis Dick Bought Yesterday
June 24, 2021
On Wednesday’s PreMarket Prep, co-hosts Joel Elconin and Dennis Dick discussed the bullish chart setups in several tech stocks. ...
Via
Benzinga
Why Lilly Shares Are Moving Thursday
June 24, 2021
Eli Lilly and Company (NYSE: LLY) shares are advancing solidly Thursday following an update the company provided on its Alzheimer's program. What Happened: Lilly, which...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 24, 2021
Gainers Aravive (NASDAQ:ARAV) stock moved upwards by 21.61% to $6.47 during Thursday's pre-market session. The company's market cap stands at $131.9 million. Arcus...
Via
Benzinga
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
June 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
< Previous
1
2
...
32
33
34
35
36
37
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.